Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-κB pathway by binding to CRY1

Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the ‘resistant’ C57Bl/6J mouse strain

(2018) Melissa Uil et al.   Scientific Reports

miR-181c protects CsA-induced renal damage and fibrosis through inhibiting EMT

(2017) Wenjuan Sun et al.   FEBS LETTERS

miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer

(2017) Xiaofeng Guo et al.   Cell Death & Disease

miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2

(2016) XIAOJUAN ZHAO et al.   Oncology Letters

Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

(2016) Swarna Gaddam et al.   BMC Pulmonary Medicine

Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NF-κB pathway

(2015) Lei Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

TLR2–MyD88–NF-κB pathway is involved in tubulointerstitial inflammation caused by proteinuria

(2015) Li-Hong Ding et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

MicroRNA-181c negatively regulates the inflammatory response in oxygen-glucose-deprived microglia by targeting Toll-like receptor 4

(2015) Li Zhang et al.   JOURNAL OF NEUROCHEMISTRY

Unknown

(2015) Francine Marques et al.   MOLECULAR MEDICINE

The role of endoglin in kidney fibrosis

(2014) Jose M. Muñoz-Felix et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury

(2014) Kristin Moreth et al.   MATRIX BIOLOGY

Ulinastatin attenuates renal interstitial inflammation and inhibits fibrosis progression in rats under unilateral ureteral obstruction

(2014) GUO-TAO JIANG et al.   Molecular Medicine Reports

MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets

(2014) R Su et al.   ONCOGENE

A Within-Patient Analysis for Time-Varying Risk Factors of CKD Progression

(2013) L. Li et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

MicroRNA-185 oscillation controls circadian amplitude of mouse Cryptochrome 1 via translational regulation

(2013) Kyung-Ha Lee et al.   MOLECULAR BIOLOGY OF THE CELL

Decreased miR-181a Expression in Monocytes of Obese Patients Is Associated with the Occurrence of Metabolic Syndrome and Coronary Artery Disease

(2012) Maarten Hulsmans et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos

(2012) Chaoneng Wu et al.   JOURNAL OF LIPID RESEARCH

Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486

(2012) Jing Xu et al.   KIDNEY INTERNATIONAL

Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines

(2012) R. Narasimamurthy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chronic kidney disease

(2011) Andrew S Levey et al.   LANCET

MicroRNAs as mediators and therapeutic targets in chronic kidney disease

(2011) Johan M. Lorenzen et al.   Nature Reviews Nephrology

Circulating microRNA expression is reduced in chronic kidney disease

(2011) Calida S. Neal et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury

(2010) Jianlin Chen et al.   KIDNEY INTERNATIONAL

Comprehensive analysis of microRNA-mRNA co-expression in circadian rhythm

(2009) Young-Ji Na et al.   EXPERIMENTAL AND MOLECULAR MEDICINE